ICU Medical Inc

ICUI: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
P#HLOCK|yTLOCK|wB@Pr!W

ICU Medical Earnings: Incremental Operational Improvements Could Provide Profit Catalysts in 2026

For the fourth quarter, ICU Medical delivered 2% organic revenue growth year over year and expanded gross margin to 38%, up from 36% a year ago. The company provided 2026 guidance featuring an adjusted EPS midpoint of $8.10, which would represent 5.3% growth over 2025.

Sponsor Center